{"created":"2023-06-20T15:50:32.430380+00:00","id":3345,"links":{},"metadata":{"_buckets":{"deposit":"52b0d2f9-3736-4b8c-bea5-2c2c12d69de1"},"_deposit":{"created_by":28,"id":"3345","owners":[28],"pid":{"revision_id":0,"type":"depid","value":"3345"},"status":"published"},"_oai":{"id":"oai:redcross.repo.nii.ac.jp:00003345","sets":["172:173:175"]},"author_link":["7940","7930","7935","7936","7929","7937","7939","7934","7933","7938","7932","7931"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2012-12","bibliographicIssueDateType":"Issued"},"bibliographicPageEnd":"62","bibliographicPageStart":"57","bibliographicVolumeNumber":"30","bibliographic_titles":[{"bibliographic_title":"日本赤十字社和歌山医療センター医学雑誌"},{"bibliographic_title":"Medical Journal of Japanese Red Cross Society Wakayama Medical Center","bibliographic_titleLang":"en"}]}]},"item_10001_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"基質拡張型β-ラクタマーゼ(extended-spectrum β-lactamases:ESBLs)は、その耐性遺伝子がプラスミド上に存在するため伝播しやすい特性をもち、院内感染の原因菌として重要である。また、近年では市中における拡散も問題となっている。こうした背景をもとに、2006年〜2010年の過去5年間における日本赤十字社和歌山医療センターでのESBL産生Escherichia coliおよびKlebsiella pneumoniaeの検出率と、薬剤感性率を調査した。その結果、ESBL産生E.coliは3.9%から10.8%、ESBL産生K.pneumoniaeは2.3%から15.3%と、ともに増加しており、外来由来株での増加も両菌種で認められた。両菌種において、カルバペネム系薬であるimipenemに対する耐性は認めなかったが、ニューキノロン系薬のlevofloxacinは約25%のみが感性株であった。以上より、入院外来に関わらずESBL産生菌の可能性を考慮し、抗菌薬の適正使用を行うとともに、手指衛生をはじめとする感染対策が重要であると考える。","subitem_description_type":"Abstract"}]},"item_10001_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{}],"names":[{"name":"Nakaie,  Ayumi"}]},{"nameIdentifiers":[{}],"names":[{"name":"Nishi, Haruka"}]},{"nameIdentifiers":[{}],"names":[{"name":"Hara, Mikinari"}]},{"nameIdentifiers":[{}],"names":[{"name":"Idomuki, Masaya"}]},{"nameIdentifiers":[{}],"names":[{"name":"Ikeda, Norio"}]},{"nameIdentifiers":[{}],"names":[{"name":"Miyaki, Yasuo"}]}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"日本赤十字社和歌山医療センター"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"1341-9927","subitem_source_identifier_type":"ISSN"}]},"item_10001_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"中家, 歩美"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"西, 春香"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"原, 幹也"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"井戸向, 昌哉"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"池田, 紀男"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"宮木, 康夫"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2013-12-01"}],"displaytype":"simple","filename":"09（中家歩美）.pdf","filesize":[{"value":"744.9 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"Wakayama30_09","url":"https://redcross.repo.nii.ac.jp/record/3345/files/09（中家歩美）.pdf"},"version_id":"8b5f3614-c2b7-4c2d-b3de-76c0b1cac323"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"基質拡張型β-ラクタマーゼ","subitem_subject_scheme":"Other"},{"subitem_subject":"抗細菌剤","subitem_subject_scheme":"Other"},{"subitem_subject":"院内感染","subitem_subject_scheme":"Other"},{"subitem_subject":"手指衛生","subitem_subject_scheme":"Other"},{"subitem_subject":"感染対策","subitem_subject_scheme":"Other"},{"subitem_subject":"薬剤感性率","subitem_subject_scheme":"Other"},{"subitem_subject":"年次推移","subitem_subject_scheme":"Other"},{"subitem_subject":"extended-spectrum β-lactamases(ESBLs)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Beta-Lactamases","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Escherichia coli","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Klebsiella pneumoniae","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"当センターにおける基質拡張型β-ラクタマーゼ(ESBL)産生菌の検出率および薬剤感性率状況","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"当センターにおける基質拡張型β-ラクタマーゼ(ESBL)産生菌の検出率および薬剤感性率状況"}]},"item_type_id":"10001","owner":"28","path":["175"],"pubdate":{"attribute_name":"公開日","attribute_value":"2013-04-24"},"publish_date":"2013-04-24","publish_status":"0","recid":"3345","relation_version_is_last":true,"title":["当センターにおける基質拡張型β-ラクタマーゼ(ESBL)産生菌の検出率および薬剤感性率状況"],"weko_creator_id":"28","weko_shared_id":-1},"updated":"2023-06-20T19:30:53.684507+00:00"}